Me medicine vs. we medicine: reclaiming biotechnology for the common good

Vaunted biotechnologies such as direct-to-consumer genetic testing, pharmacogenetics in cancer care, private umbilical cord blood banking, and neurocognitive enhancement seem to promise exponential and genome-specific benefits for individuals.

In some cases, these technologies have shown significant potential, yet in others, they have produced negligible or even negative results.

So why is 'Me Medicine' rapidly edging out 'We Medicine,' and how has our commitment to collective health suffered as a result?

This book explores this question and much more.